24-h systolic blood pressure variability
Biomarker1 paper4 findings
A human study associates 24-hour systolic blood pressure variability with greater left ventricular mass index, left ventricular hypertrophy, target-organ damage and microalbuminuria in untreated white-coat hypertension.
- Humans1
Associations
4Microalbuminuria
upin humans1
1 study
Microalbuminuria
upin humans1
24-h systolic blood pressure variability is associated with microalbuminuria in humans (β=0.105, 95% CI 0.052-0.157).
Humansuntreated white-coat hypertension
Short-Term 24-h Systolic Blood Pressure Variability and Subclinical Target-Organ Damage in White-Coat Hypertension: A Retrospective Cross-Sectional Study · Vascular health and risk management · 16 Sep 2026
Left ventricular mass index
upin humans1
1 study
Left ventricular mass index
upin humans1
24-h systolic blood pressure variability is associated with left ventricular mass index in humans (β=2.23 g/m2, 95% CI 0.33-4.12).
Humansuntreated white-coat hypertension
Short-Term 24-h Systolic Blood Pressure Variability and Subclinical Target-Organ Damage in White-Coat Hypertension: A Retrospective Cross-Sectional Study · Vascular health and risk management · 16 Sep 2026
Left ventricular hypertrophy
upin humans1OR 1.3
1 study
Left ventricular hypertrophy
upin humans1OR 1.3
24-h systolic blood pressure variability is associated with left ventricular hypertrophy in humans (OR 1.30, 95% CI 1.08-1.60).
Humansuntreated white-coat hypertension
Short-Term 24-h Systolic Blood Pressure Variability and Subclinical Target-Organ Damage in White-Coat Hypertension: A Retrospective Cross-Sectional Study · Vascular health and risk management · 16 Sep 2026
Target-organ damage
upin humans1OR 1.25
1 study
Target-organ damage
upin humans1OR 1.25
24-h systolic blood pressure variability is associated with target-organ damage in humans (OR 1.25, 95% CI 1.05-1.52).
Humansuntreated white-coat hypertension
Short-Term 24-h Systolic Blood Pressure Variability and Subclinical Target-Organ Damage in White-Coat Hypertension: A Retrospective Cross-Sectional Study · Vascular health and risk management · 16 Sep 2026